TURKISH JOURNAL OF NEPHROLOGY, cilt.28, sa.4, ss.286-292, 2019 (ESCI)
Objective: It is still unclear which parameters will be used when starting renal replacement therapies (RRT) in end stage kidney disease patients. We planned this retrospective study to determine the eGFR in the transition to RRT in our patient population and the RRT preferences with laboratory values.